Allarity Therapeutics, Inc.
ALLR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $23 | $16 | $1 | $2 |
| - Cash | $17 | $18 | $25 | $20 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $6 | -$1 | -$23 | -$16 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$2 | -$3 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$2 | -$3 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.19 | -0.149 | -0.245 | -1.021 |
| % Growth | -27.5% | 39.1% | 76% | – |
| Operating Cash Flow | -$3 | -$5 | -$3 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3 | -$5 | -$3 | -$4 |